These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27818183)

  • 21. Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
    Modh RP; Kumar SP; Jasrai YT; Chikhalia KH
    Arch Pharm (Weinheim); 2013 Nov; 346(11):793-804. PubMed ID: 24591157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of promising inhibitory heterocyclic compounds against acetylcholinesterase using QSAR, ADMET, biological activity, and molecular docking.
    Nguyen HD; Kim MS
    Comput Biol Chem; 2023 Jun; 104():107872. PubMed ID: 37119698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives.
    Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK
    Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual screening of acetylcholinesterase inhibitors using the Lipinski's rule of five and ZINC databank.
    Nogara PA; Saraiva Rde A; Caeran Bueno D; Lissner LJ; Lenz Dalla Corte C; Braga MM; Rosemberg DB; Rocha JB
    Biomed Res Int; 2015; 2015():870389. PubMed ID: 25685814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR applications during last decade on inhibitors of acetylcholinesterase in Alzheimer's disease.
    Wong KY; Duchowicz PR; Mercader AG; Castro EA
    Mini Rev Med Chem; 2012 Sep; 12(10):936-46. PubMed ID: 22303974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.
    Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD
    Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.
    Kiametis AS; Silva MA; Romeiro LA; Martins JB; Gargano R
    J Mol Model; 2017 Feb; 23(2):67. PubMed ID: 28185116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.
    Telpoukhovskaia MA; Patrick BO; Rodríguez-Rodríguez C; Orvig C
    Mol Biosyst; 2013 Apr; 9(4):792-805. PubMed ID: 23435553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies.
    Pant S; Kumar K R; Rana P; Anthwal T; Ali SM; Gupta M; Chauhan M; Nain S
    ACS Chem Neurosci; 2024 Feb; 15(4):783-797. PubMed ID: 38320262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
    Li Y; Peng P; Tang L; Hu Y; Hu Y; Sheng R
    Bioorg Med Chem; 2014 Sep; 22(17):4717-25. PubMed ID: 25082512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.
    Asadabadi EB; Abdolmaleki P; Barkooie SM; Jahandideh S; Rezaei MA
    Comput Biol Med; 2009 Dec; 39(12):1089-95. PubMed ID: 19854437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore Modeling, virtual and in vitro screening for acetylcholinesterase inhibitors and their effects on amyloid-β self- assembly.
    Bag S; Tulsan R; Sood A; Datta S; Török M
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):2-14. PubMed ID: 22734711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.
    Recanatini M; Cavalli A; Hansch C
    Chem Biol Interact; 1997 Aug; 105(3):199-228. PubMed ID: 9291997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
    Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
    J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
    Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
    Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.